Ethical considerations in biomedical HIV prevention trials
Well into the third decade of the HIV epidemic, there remains no effective HIV preventive vaccine, microbicide, product or drug to reduce the risk of HIV acquisition. As the numbers of those infected by HIV and dying from AIDS continue to increase, the need for such biomedical HIV preventive interve...
Đã lưu trong:
| Định dạng: | Sách |
|---|---|
| Ngôn ngữ: | Undetermined |
| Được phát hành: |
Geneva, Switzerland
UNAIDS
c2007
|
| Những chủ đề: | |
| Các nhãn: |
Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| Thư viện lưu trữ: | Trung tâm Học liệu Trường Đại học Cần Thơ |
|---|
| LEADER | 01283nam a2200205Ia 4500 | ||
|---|---|---|---|
| 001 | CTU_159308 | ||
| 008 | 210402s9999 xx 000 0 und d | ||
| 082 | |a 614.599392 | ||
| 082 | |b E84 | ||
| 245 | 0 | |a Ethical considerations in biomedical HIV prevention trials | |
| 245 | 0 | |c Joint United Nations Programme on HIV/AIDS (UNAIDS) | |
| 260 | |a Geneva, Switzerland | ||
| 260 | |b UNAIDS | ||
| 260 | |c c2007 | ||
| 520 | |a Well into the third decade of the HIV epidemic, there remains no effective HIV preventive vaccine, microbicide, product or drug to reduce the risk of HIV acquisition. As the numbers of those infected by HIV and dying from AIDS continue to increase, the need for such biomedical HIV preventive interventions becomes ever more urgent. Several such products are at various stages of development, including some currently in phase III efficacy trials. The successful development of effective HIV preventive interventions requires that many different candidates be studied simultaneously in different populations around the world. | ||
| 650 | |a HIV infections,Clinical trials | ||
| 650 | |x Moral and ethical aspects,Prevention,Moral ethical aspects | ||
| 650 | |y Nhiễm HIV | ||
| 904 | |i Trọng Hiếu | ||
| 980 | |a Trung tâm Học liệu Trường Đại học Cần Thơ | ||